Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Agnelli

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2013
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcomeKatia Todoerti, Luca Agnelli, Sonia Fabris, et al.
Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Endocrine|June 23, 2026
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer centerElena Colombo, Elisa Ortolan, Stefano Cavalieri, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
Cancers|November 10, 2020
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine AvailabilityMartina Chiu, Denise Toscani, Valentina Marchica, et al.
American Journal of Hematology|March 5, 2019
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphomaFrancesco Maura, Luca Agnelli, Daniel Leongamornlert, et al.
American Journal of Hematology|October 10, 2012
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profilesLaura Mosca, Pellegrino Musto, Katia Todoerti, et al.
Frontiers in Oncology|August 22, 2025
Genomic instability and <i>CCNE1</i> amplification as emerging biomarkers for stratifying high-grade serous ovarian cancerElena Conca, Daniele Lorenzini, Emanuela Minna, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 20, 2013
Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcomeKatia Todoerti, Luca Agnelli, Sonia Fabris, et al.
Blood|June 9, 2016
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive targetMarina Bolzoni, Martina Chiu, Fabrizio Accardi, et al.
Leukemia & Lymphoma|April 11, 2015
Association between gene and miRNA expression profiles and stereotyped subset #4 B-cell receptor in chronic lymphocytic leukemiaFrancesco Maura, Giovanna Cutrona, Laura Mosca, et al.
Endocrine|June 23, 2026
Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer centerElena Colombo, Elisa Ortolan, Stefano Cavalieri, et al.
JCO Precision Oncology|June 11, 2025
Real-World Outcomes of Molecular Tumor Board Treatment RecommendationsFederico Nichetti, Marta Brambilla, Matteo Duca, et al.
Cancers|November 10, 2020
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine AvailabilityMartina Chiu, Denise Toscani, Valentina Marchica, et al.
American Journal of Hematology|March 5, 2019
Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphomaFrancesco Maura, Luca Agnelli, Daniel Leongamornlert, et al.
American Journal of Hematology|October 10, 2012
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profilesLaura Mosca, Pellegrino Musto, Katia Todoerti, et al.
Frontiers in Oncology|August 22, 2025
Genomic instability and <i>CCNE1</i> amplification as emerging biomarkers for stratifying high-grade serous ovarian cancerElena Conca, Daniele Lorenzini, Emanuela Minna, et al.
Pageof 12